Last 12 months
Inside the activity.
0 purchase rows · 73 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 42 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2020 Filed Aug 19, 2020 23:52 UTC |
FUCCI DAVIDFormer VP of Operations
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 200 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001654954-20-009368 · section16.xml · derivative · entry 3 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,800 Underlying: Common Stock · 200 shares Expires 2020-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:52 UTC |
FUCCI DAVIDFormer VP of Operations
|
SaleCommon Stock | 200 | $2.10 | $420.00 |
DisclosureSEC source: 0001654954-20-009368 · section16.xml · nonDerivative · entry 2 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 23:52 UTC |
FUCCI DAVIDFormer VP of Operations
|
Exercise / conversionCommon Stock | 200 | $1.68 | $336.00 |
DisclosureSEC source: 0001654954-20-009368 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · Former VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2020 Filed Aug 14, 2020 22:08 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 19,900 | $2.07 | $41,193.00 |
DisclosureSEC source: 0001654954-20-009211 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,816 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.11, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 22:08 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 20,000 | $2.09 | $41,800.00 |
DisclosureSEC source: 0001654954-20-009211 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,716 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.06 to $2.13, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 22:08 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 20,000 | $2.09 | $41,800.00 |
DisclosureSEC source: 0001654954-20-009211 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 638,716 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.06 to $2.14, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 01:47 UTC |
SLAYEN HOWARD TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,711 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001654954-20-007753 · section16.xml · derivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,711 Underlying: Common Stock · 14,711 shares Expires 2027-07-14 F1 · derivative.exercise_date: The total number of shares became exercisable on this date. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 01:41 UTC |
Erickson GaynDirector · President and CEO
|
GrantCommon Stock | 77,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007751 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,716 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 01:37 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
GrantCommon Stock | 35,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007749 · section16.xml · nonDerivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,968 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 01:30 UTC | GrantCommon Stock | 11,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007747 · section16.xml · nonDerivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,148 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
|
| July 14, 2020 Filed Jul 16, 2020 01:26 UTC |
ROGERS VERNONExec. VP Sales and Marketing
|
GrantCommon Stock | 20,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007745 · section16.xml · nonDerivative · entry 1 ROGERS VERNON · CIK 0001756642 · Exec. VP Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,163 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 01:21 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
GrantCommon Stock | 16,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007743 · section16.xml · nonDerivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,636 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| July 14, 2020 Filed Jul 17, 2020 00:25 UTC |
POSEDEL RHEA JDirector
|
GrantCommon Stock | 9,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007784 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 911,831 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
| July 14, 2020 Filed Jul 17, 2020 01:26 UTC |
ROSATI MARIO MDirector
|
GrantCommon Stock | 8,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007788 · section16.xml · nonDerivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 31,533 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. F2 · ownership.nature: Shares held by Mario M. Rosati and Danelle Storm Rosati, Trustees of the Rosati Family Trust dated May 23, 1997. Read SEC document |
| July 14, 2020 Filed Jul 17, 2020 00:26 UTC |
OLIPHANT LAURADirector
|
GrantCommon Stock | 9,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007786 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,456 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
| July 14, 2020 Filed Jul 17, 2020 00:25 UTC |
Schneider John M.Director
|
GrantCommon Stock | 8,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007785 · section16.xml · nonDerivative · entry 1 Schneider John M. · CIK 0001625605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,442 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC |
Erickson GaynDirector · President and CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,746 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · derivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,746 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC |
Erickson GaynDirector · President and CEO
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 84,254 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,254 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC |
Erickson GaynDirector · President and CEO
|
Tax withholdingCommon Stock | 782 | $1.93 | $1,509.26 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,091 Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC |
Erickson GaynDirector · President and CEO
|
Exercise / conversionCommon Stock | 95,000 | $1.28 | $121,600.00 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC |
FUCCI DAVIDVP of Operations
|
SaleCommon Stock | 547 | $1.52 | $831.55 |
DisclosureSEC source: 0001654954-20-005520 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488 Read SEC document |
| May 12, 2020 Filed May 13, 2020 01:12 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,438 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-005268 · section16.xml · derivative · entry 2 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,438 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| May 12, 2020 Filed May 13, 2020 01:12 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
Exercise / conversionCommon Stock | 3,438 | $1.28 | $4,400.64 |
DisclosureSEC source: 0001654954-20-005268 · section16.xml · nonDerivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 01:34 UTC |
POSEDEL RHEA JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,956 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-20-004301 · section16.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,956 Underlying: Common Stock · 17,956 shares Expires 2027-04-21 F1 · derivative.exercise_date: The total number of shares became exercisable on this date. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 01:34 UTC |
ROSATI MARIO MDirector
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 14,108 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-20-004300 · section16.xml · derivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,108 Underlying: Common Stock · 14,108 shares Expires 2027-04-21 F1 · derivative.exercise_date: The total number of shares became exercisable on this date. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 01:06 UTC |
Schneider John M.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,365 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-20-004297 · section16.xml · derivative · entry 1 Schneider John M. · CIK 0001625605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,365 Underlying: Common Stock · 14,365 shares Expires 2027-04-21 F1 · derivative.exercise_date: The total number of shares became exercisable on this date. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 01:06 UTC |
SLAYEN HOWARD TDirector
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 16,160 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-20-004296 · section16.xml · derivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,160 Underlying: Common Stock · 16,160 shares Expires 2027-04-21 F1 · derivative.exercise_date: The total number of shares became exercisable on this date. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 00:02 UTC |
OLIPHANT LAURADirector
|
GrantCommon Stock | 9,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-004293 · section16.xml · nonDerivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,451 F1 · shares: RSU shares issued in-lieu of cash for BOD fee. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:50 UTC |
Erickson GaynDirector · President and CEO
|
Tax withholdingCommon Stock | 6,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-004349 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,873 Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:50 UTC |
Erickson GaynDirector · President and CEO
|
GrantCommon Stock | 15,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-004349 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,926 F1 · shares: Represents shares of common stock issued for bonus. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 23:46 UTC |
Erickson GaynDirector · President and CEO
|
OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-20-003758 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,015 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 23:17 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-20-003755 · section16.xml · nonDerivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,506 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 22:55 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-20-003753 · section16.xml · nonDerivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,287 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 17:11 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 20,000 | $1.62 | $32,400.00 |
DisclosureSEC source: 0001654954-20-003670 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.70, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:23 UTC |
POSEDEL RHEA JDirector
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-001551 · section16.xml · derivative · entry 4 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:23 UTC |
POSEDEL RHEA JDirector
|
SaleCommon Stock | 30,000 | $2.27 | $68,100.00 |
DisclosureSEC source: 0001654954-20-001551 · section16.xml · nonDerivative · entry 2 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 01:23 UTC |
POSEDEL RHEA JDirector
|
Exercise / conversionCommon Stock | 30,000 | $1.28 | $38,400.00 |
DisclosureSEC source: 0001654954-20-001551 · section16.xml · nonDerivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY2019 of 1,960 shares on 11/22/2019. The closing price was $2.02 per share. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:27 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive stock option (right to buy) · Derivative | 1,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-001543 · section16.xml · derivative · entry 3 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eigth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eigth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:27 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon stock | 1,000 | $2.27 | $2,270.00 |
DisclosureSEC source: 0001654954-20-001543 · section16.xml · nonDerivative · entry 2 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:27 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon stock | 1,000 | $1.28 | $1,280.00 |
DisclosureSEC source: 0001654954-20-001543 · section16.xml · nonDerivative · entry 1 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 02:09 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-001370 · section16.xml · derivative · entry 6 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 2,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 02:09 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 2,000 | $2.13 | $4,260.00 |
DisclosureSEC source: 0001654954-20-001370 · section16.xml · nonDerivative · entry 4 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.19, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 02:09 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon Stock | 2,000 | $1.28 | $2,560.00 |
DisclosureSEC source: 0001654954-20-001370 · section16.xml · nonDerivative · entry 3 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 02:09 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-001370 · section16.xml · derivative · entry 5 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 2,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 02:09 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 2,000 | $2.00 | $4,000.00 |
DisclosureSEC source: 0001654954-20-001370 · section16.xml · nonDerivative · entry 2 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 02:09 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon Stock | 2,000 | $1.28 | $2,560.00 |
DisclosureSEC source: 0001654954-20-001370 · section16.xml · nonDerivative · entry 1 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 23:32 UTC |
FUCCI DAVIDVP of Operations
|
SaleCommon Stock | 546 | $2.00 | $1,092.05 |
DisclosureSEC source: 0001654954-20-001350 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,035 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 21:42 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive stock option (right to buy) · Derivative | 2,000 | $2.02 Strike: $1.28 | $4,040.00 |
DisclosureSEC source: 0001654954-20-001282 · section16.xml · derivative · entry 3 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common stock · 2,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 21:42 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon stock | 2,000 | $2.02 | $4,040.00 |
DisclosureSEC source: 0001654954-20-001282 · section16.xml · nonDerivative · entry 2 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 21:42 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon stock | 2,000 | $1.28 | $2,560.00 |
DisclosureSEC source: 0001654954-20-001282 · section16.xml · nonDerivative · entry 1 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.